AKT1 and Insulin resistance: Overexpression of OGT in the liver influences the phosphorylation of insulin-responsive proteins, namely, Akt and insulin receptor substrate 1 (IRS-1), which inhibits the kinase activity of Akt and induces the serine phosphorylation of IRS1, thus resulting in insulin resistance and dyslipidemia [41].